Treatment options for patients with newly diagnosed or recurrent thoracic malignancy are in a continual state of evolution. The MTTC provides pathologists, radiologists, surgeons, medical oncologists and radiation oncologists a forum in which to introduce new treatment options and protocols to the entire team, resulting in a more cohesive and comprehensive plan of care for each patient regardless of the subspecialty via which they entered our Cancer Center’s care.
Communication between the various treating disciplines is crucial in keeping each provider up-to-date on current treatment options. This forum allows the subspecialists to review each patient’s unique set of physical and psychosocial factors and offer contributions to their care plan which might not otherwise have been recognized.
The goal is to improve communication amongst the various oncologic disciplines, and increasing each physician and allied health professional’s fund of knowledge and comprehension of available and optimal treatment options.
- Medical oncologists
- Radiation oncologists
- Surgical oncologists
- Thoracic surgeons
- Chest radiologists
- Nuclear medicine radiologists
- Pathologists
- Pulmonologists
- Gastroenterologists
- Allied health professionals
Participants who engage in this educational intervention will be able to:
- Comply with evidence-based recommendations for treatment of newly diagnosed and recurrent thoracic malignancies
- Ensure current treatment techniques and options, including research protocols, available to thoracic cancer patients
- Identify and evaluate personal patient care practices and outcomes (based on outcomes tools developed both inside our institution and nationally) and adjust treatment strategies accordingly
In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
- Mandana Kamgar, MD
- Smitha Menon, MD
- Candice Johnstone, MD, MPH
- Robert Hellman, MD
- Diane Montenero, NP
- Luis Sosa, MD
- Thomas Giever, MD
Elizabeth Gore, MD - Monica Shukla, MD
- Colin Mooney, MD
- Bryan Benn, MD
- Jonathan Thompson, MD
- Paul Linsky, MD
- Yuri Sheinin, MD
- Juan Carlos Felix, MD
- Mario Gasparri, MD
- Pat Quinn-Casper, NP
- Sakti Chakrabarti, MD
- Christopher Bennett, MD
- David Johnstone, MD
- Malika Siker, MD
- Luba Frank, MD
- Tracy Erlitz, RN
In accordance with the ACCME® Standards for Commercial Support Six, all in control of content must disclose any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
Name | Company | Role |
---|---|---|
Jonathan Kurman, MD | Level EX | Consultant |
Medtronic | Consultant | |
Boston Scientific | Consultant |
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.